Successful long-term antibiotic suppressive therapy in a case of prosthetic valve endocarditis and a case of extensive aortic and subclavian graft infection.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 10 04 2019
accepted: 13 05 2019
pubmed: 28 5 2019
medline: 9 9 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

The indication for surgical valve replacement in cases of infective endocarditis is well defined in current guidelines. However, some patients are not fit or willing to undergo major surgical procedures. Interestingly, to the best of our knowledge, there is scarce information in the literature on how to deal with such cases and what might be the outcome. We present two complicated cases of prosthetic infective endocarditis with definite indication for replacement of involved foreign material, who were treated successfully with long-term suppressive antibiotic therapy. These two cases demonstrate that individualized long-term antibiotic suppressive therapy might be effective in selected patients with complicated PVE unfit or unwilling to undergo high-risk cardiothoracic surgical interventions.

Identifiants

pubmed: 31123929
doi: 10.1007/s15010-019-01321-6
pii: 10.1007/s15010-019-01321-6
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-136

Références

JAMA. 2007 Mar 28;297(12):1354-61
pubmed: 17392239
Ann Lab Med. 2015 Mar;35(2):205-11
pubmed: 25729722
Heart. 2005 Jul;91(7):954-9
pubmed: 15958370
Intern Med. 1996 Dec;35(12):979-83
pubmed: 9030999
Antimicrob Agents Chemother. 2014 Sep;58(9):5576-80
pubmed: 24957833
Heart. 2005 May;91(5):571-5
pubmed: 15831635
Scand J Infect Dis. 2011 Dec;43(11-12):837-47
pubmed: 21756019
Circulation. 2015 Oct 13;132(15):1435-86
pubmed: 26373316
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Int J Antimicrob Agents. 2013 Aug;42(2):190-1
pubmed: 23796892

Auteurs

Arno M Lechner (AM)

Division Medizinische Mikrobiologie, Universitätsinstitut für Medizinisch-Chemische Labordiagnostik, Paracelsus Medizinische Privatuniversität Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria. a.lechner@salk.at.

Ingrid Pretsch (I)

Universitätsklinik für Innere Medizin II, Paracelsus Medizinische Privatuniversität Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

Uta Hoppe (U)

Universitätsklinik für Innere Medizin II, Paracelsus Medizinische Privatuniversität Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

Rainald Seitelberger (R)

Universitätsklinik für Herzchirurgie, Gefäßchirurgie und endovaskuläre Chirurgie, Paracelsus Medizinische Privatuniversität Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

Christian Dinges (C)

Universitätsklinik für Herzchirurgie, Gefäßchirurgie und endovaskuläre Chirurgie, Paracelsus Medizinische Privatuniversität Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH